Skip to main content
2026 Prospectus
The Healthcare ExecutiveExecutive News

New tariffs on 60 trading partners take effect. A supply cost plan

New tariffs of 10% or 12.5% on imports from 60 U.S. trading partners took effect July 24, and hospital supply chain leaders now need to work out which of their products are covered and how much cost will flow through.

New tariffs on 60 trading partners take effect. A supply cost plan

Executive takeaway

Do not wait for supplier notices to estimate exposure. Map origin and contract terms on your top items now, so finance can budget and clinicians can vet alternatives.

Article

What took effect

The U.S. Trade Representative announced the duties on July 23 after a Section 301 investigation into whether trading partners ban imports made with forced labor. Countries that have committed to adopt and enforce such a ban face a 10% rate. Those that USTR found had not adopted one face 12.5%. USTR says the 60 economies covered account for 99.4% of U.S. imports.

The action does carve some products out. According to the AHA, the notice excludes goods already subject to Section 232 tariffs, goods that qualify under the U.S.-Mexico-Canada Agreement, and certain pharmaceuticals and pharmaceutical ingredients. Medical devices and supplies were not named among the exclusions.

Why hospitals should pay attention

Earlier this month the AHA asked USTR to exempt medications, devices and other health care equipment and supplies, arguing that U.S. health care relies heavily on foreign sources for many of these products. That broad exemption did not happen. The pharmaceutical carve-out helps, but it is partial, and many disposables, instruments and equipment components are made abroad.

Suppliers and distributors will decide how much of the new duty to absorb and how much to pass on. Some may invoke contract clauses that allow price changes tied to tariffs or other government actions. Hospitals working with thin operating margins have little room to absorb a broad price increase on imported supplies.

A practical plan for supply chain and finance

  • Map country of origin. Ask your group purchasing organization and top distributors for origin data on your highest-spend and highest-volume items, and check which fall under the exclusions.
  • Read the contract language. Identify which agreements allow tariff-related price increases, what notice is required and whether you can audit the pass-through.
  • Prioritize clinical risk. Flag single-source items that could face shortages if suppliers shift production, and identify approved alternatives in advance.
  • Bring clinicians in early. Value analysis committees should be ready to review substitutions quickly.
  • Update the forecast. Build a supply expense scenario that assumes partial pass-through over the next two quarters.

Archive entry for Jul 25, 2026, added Nov. 11, 2026.

Sources

Quarterly Brief

Get the Quarterly Brief by email.

A practical executive agenda for hospital and health system leaders, four times a year.

Sent by The Healthcare Executive. Unsubscribe at any time. See our Privacy Policy.